Navigation Links
Vermillion Appoints Distribution Partner for OVA1® in Israel and the Palestine Territories
Date:8/3/2011

AUSTIN, Texas, Aug. 3, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, today announced entry into a definitive agreement with Pronto Diagnostics Ltd. as its exclusive distributor of OVA1 in Israel and the Palestinian territories. Pronto Diagnostics offers a clinical lab, regulatory expertise, a broad distribution network, and years of experience distributing oncology products into the Israeli market. They will begin offering the test into the private pay market while simultaneously starting the regulatory process to make the test available to the publicly-funded Israeli HMO market.

"This distribution agreement is a significant milestone in making this important new test available to women outside the United States. Israel and the Palestinian territories represent a new market opportunity of approximately 6 million women. With the availability of OVA1, physicians in Israel and the Palestinian territories can direct patients to the most appropriate surgeon, promoting more favorable treatment outcomes," said Gail S. Page, President and CEO of Vermillion, Inc. "This further supports our expansion efforts as we continue to develop our international strategy in concert with the efforts already underway in the US."

"We are pleased by the confidence granted to us by Vermillion for the exclusive distribution of OVA1 in Israel and the Palestinian territories. This relationship will enable Pronto Diagnostics to enlarge its offering of very innovative products in the field of oncology diagnostics," said Nir Navot, PhD, CEO of Pronto Diagnostics.

About OVA1:

OVA1 is the first protein-based in vitro diagnostic multi-variate index assay (IVDMIA), a new class of state of the art software-based diagnostics, cleared by the FDA. The test utilizes five well-established biomarkers -- Transthyretin (TT or prealbumin), Apolipoprote
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vermillion Receives Award From the Society of Gynecologic Oncologists
2. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
3. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
4. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
5. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
6. Vermillion Presents Critical Data From Its OVA1 Clinical Trial
7. Vermillion Announces the Reappointment of Officers and Confirmation of Director
8. Vermillion to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
9. Vermillion Announces $43.05 Million Private Placement of Common Stock
10. Vermillion Files Plan of Reorganization
11. Vermillion Files Amended Plan of Reorganization and Exchanges Debt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... -- Bayer HealthCare announced today that it has contributed ... the American Society of Clinical Oncology (ASCO) to support ... to unlock vast quantities of information about the experiences ... is proud to join ASCO and the Conquer Cancer ... help people whose lives have been affected by cancer," ...
(Date:3/5/2015)... 5, 2015   AMC Health , the ... for improving the effectiveness and efficiency of healthcare ... Anazagasty and Jared Wilstead have ... President, Strategic Client Development, and Wilstead will serve ... AMC Health,s commitment to accelerating the adoption of ...
(Date:3/5/2015)... , March 5, 2015 LUNGevity Foundation, ... Food and Drug Administration,s (FDA) approval of Bristol ... and other immunotherapy treatments add another critical new ... the power of a patient,s own immune system ... been approved specifically for patients with squamous cell ...
Breaking Medicine Technology:Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
... Pharmaceuticals, Inc. (Nasdaq: CADX ), a ... proprietary product candidates principally for use in the ... present a corporate overview at the following investment ... Stanley Global Healthcare ConferenceDate:  Tuesday, September 14, 2010 ...
... 7 UBM TechInsights is pleased to announce it ... Business Development, Medical Devices. In this role Mr. Johnson ... business in the Medical Devices sector. ...   http://www.newscom.com/cgi-bin/prnh/20100907/SF60618 ) Mr. Johnson comes to ...
Cached Medicine Technology:Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010 2UBM TechInsights Expands Presence in the Medical Devices Sector 2
(Date:3/6/2015)... Texas (PRWEB) March 06, 2015 First ... 7am today. The new facility is located at 13351 W. ... “Our experienced clinical team is ready 24-7 to provide the ... Dr. Grossman, Facility Medical Director of First Choice Emergency Room ... ribbon cutting with the South Metro Denver Chamber of Commerce ...
(Date:3/6/2015)... March 06, 2015 Truly Nolen, the ... to announce the grand opening of their first independently-owned ... area down to the Fort Mill – Rock Hill, ... February 27th, 2015 at their new location. ... years of collective experience in the pest control industry. ...
(Date:3/6/2015)... The Gluten-Free Certification Program (GFCP), ... pleased to announce that Dufflet Pastries, the ground-breaking ... their product line of gluten-free treats certified by ... as satisfying as any of their other desserts! ... contains hydrogenated fats or oils, artificial flavours, colours ...
(Date:3/6/2015)... The producers of Health Briefs TV ... Washington and vicinity. This is a city which is full ... many outdoor activities. It is also a city where healthcare ... hospitals call the city home and provide care from the ... TV program will be broadcast on CBS KLEW-TV during the ...
(Date:3/6/2015)... San Diego, CA (PRWEB) March 06, 2015 ... study findings continue to be discussed, Ford & Associates ... wake of a January 2015 filed lawsuit: Verduzco v. ... Court, Northern District of California. , “In light ... those who have used Benicar to evaluate and explore ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4
... who are regularly exposed to moderate to high levels of ... count, according to a study published in the September issue ... with painters and decorators are at highest risk. The only ... low sperm counts and low sperm activity was repeated exposure ...
... with smokers have a relatively poor diet, which adds to ... that second-hand smoke accounts for up to 24 per cent ... smoking - usually because they live with a smoker or ... offset some of the negative effects.// ,Researchers at ...
... has told the British Psychological Society that people who feel ... of the television, or going shopping are more likely to ... to disease.Those on the other hand who feel little or ... ,Researchers asked 30 students aged 18-30 to list enjoyable ...
... Sluggish growth in the first year of a boy's life greatly ... a study of Finnish children. , ,The key factor in heart ... grew in the past. It's long been known that babies with ... heart disease in adulthood as heavier babies.// , ,David Barker, an ...
... to feel drunk than non-smoking drinkers – placing them ... hearts, a new study suggests. ,The study shows nicotine ... a good model for humans.Since alcohol abusers generally "drink to ... an expected level of intoxication, say the researchers from the ...
... pesticides and solvents can further lower fertility among infertile ... may worsen the effect of pre-existing genetic or medical ... findings should be treated with caution because they involved ... farming region in Austria. But they say the dramatic ...
Cached Medicine News:
Lyphochek Hemostasis Control is a multi-analyte control to help monitor coagulation factor assays and selected thrombosis risk assays. Assayed values are available for most major instrumentation....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
Medicine Products: